Integrin Healthcare Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 17-07-2024
- Paid Up Capital ₹ 9.28 M
as on 17-07-2024
- Company Age 15 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 1.70 M
as on 17-07-2024
- Revenue 159.12%
(FY 2023)
- Profit 178.05%
(FY 2023)
- Ebitda 172.20%
(FY 2023)
- Net Worth 14.02%
(FY 2023)
- Total Assets 30.90%
(FY 2023)
About Integrin Healthcare
The Corporate was formerly known as Bindu Pharmaceuticals Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 9.28 M.
The company has closed loans amounting to ₹1.70 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Srinivas Marikanti, Sreedhar Tirumala, and Dhana Marikanti serve as directors at the Company.
- CIN/LLPIN
U24110TG2009PTC063270
- Company No.
063270
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
02 Apr 2009
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Integrin Healthcare?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Srinivas Marikanti  | Additional Director | 21-Oct-2020 | Current |
| Sreedhar Tirumala | Additional Director | 15-Feb-2024 | Current |
| Dhana Marikanti | Additional Director | 22-Jul-2021 | Current |
Financial Performance of Integrin Healthcare.
Integrin Healthcare Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 159.12% increase. The company also saw a substantial improvement in profitability, with a 178.05% increase in profit. The company's net worth Soared by an impressive increase of 14.02%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Integrin Healthcare?
In 2023, Integrin Healthcare had a promoter holding of 89.23% and a public holding of 10.77%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Integrin Lifesciences Private LimitedActive 17 years 10 monthsSrinivas Marikanti and Dhana Marikanti are mutual person
Racemic Labs Private LimitedActive 14 years 9 monthsSrinivas Marikanti and Dhana Marikanti are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Lakshmi Vilas Bank Limited Creation Date: 20 May 2014 | ₹1.70 M | Satisfied |
How Many Employees Work at Integrin Healthcare?
Unlock and access historical data on people associated with Integrin Healthcare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Integrin Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Integrin Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
